Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival

Understanding how antibody responses to SARS-CoV-2 evolve during infection may provide important insight into therapeutic approaches and vaccination for COVID-19. Here we profile the antibody responses of 162 COVID-19 symptomatic patients in the COVID-BioB cohort followed longitudinally for up to ei...

Descripción completa

Detalles Bibliográficos
Autores principales: Dispinseri, Stefania, Secchi, Massimiliano, Pirillo, Maria Franca, Tolazzi, Monica, Borghi, Martina, Brigatti, Cristina, De Angelis, Maria Laura, Baratella, Marco, Bazzigaluppi, Elena, Venturi, Giulietta, Sironi, Francesca, Canitano, Andrea, Marzinotto, Ilaria, Tresoldi, Cristina, Ciceri, Fabio, Piemonti, Lorenzo, Negri, Donatella, Cara, Andrea, Lampasona, Vito, Scarlatti, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113594/
https://www.ncbi.nlm.nih.gov/pubmed/33976165
http://dx.doi.org/10.1038/s41467-021-22958-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113594/
https://www.ncbi.nlm.nih.gov/pubmed/33976165
http://dx.doi.org/10.1038/s41467-021-22958-8

Ejemplares similares